The Human Placenta Project: Placental Structure and Function in Real Time

Panel Discussion: Shared Pathophysiological Processes That May Be Assessed Using Knowledge and Technologies From Other Fields 
(6-Minute Presentations on the Specific Dysfunction and Its Relevance, Followed by Discussion)

• Anatomy and Tissue Structure: Susan Fisher (PDF - 5.9 MB)
• Utero-Placental Perfusion: Kathleen Schmainda (PDF - 2.2 MB)
   
• Tissue and Cellular Metabolism: Nick Illsley (PDF - 735 KB)
   
• Immunology, Inflammation: Gil Mor (PDF - 900 KB)
   

Breakout Sessions: Shared Pathophysiological Processes that may be Assessed Using Knowledge and Technologies from Other Fields

• Breakout 1: Anatomy and Tissue Structure: Led by Susan Fisher
• Breakout 2: Utero-Placental Perfusion: Led by Kathleen Schmainda
   
• Breakout 3: Tissue and Cellular Metabolism (e.g., Nutrient Transfer, Biochemistry, -omics): Led by Nick Illsley
• Breakout 4: Immunology, Inflammation (e.g., Graft vs. Host Interactions): Led by Gil Mor

Charge to Breakout Sessions:

• What functions are important to evaluate in real time?
• What are the current state-of-the-art approaches in obstetrics for assessing these processes?
• How are these processes assessed in other fields?
• What technologies might be applicable to HPP?
• What technologies need to be developed to address the pathophysiologic process?

Panel Presentation: Applying Technologies To Study the Placenta in Real Time: Currently Utilized Imaging Technologies—How To Optimize or Further Their Use
(6-Minute Presentations, Followed by Discussion)

• Ultrasound, Dopple: Alfred Abuhamad (PDF - 1.1 MB)
   
• MRI, fMRI, MR angiography: John Sled (PDF - 737 KB)

Breakout Sessions: Currently Utilized Imaging Technologies—How To Optimize or Further Their Use

• Breakout 1: Ultrasound: Led by Alfred Abuhamad
   
• Breakout 2: MRI: Led by John Sled
   

Charge to Breakout Groups:

• What are the "adjacent possible" to application in obstetrics for each technology?
• What technologies might be applicable to HPP?
• What technologies need to be developed to address the pathophysiologic process?
• Describe what needs to be done to develop/stimulate/
  encourage/facilitate this area to move forward to understand human placental structure and function in real time.
• Are there initial steps that must first occur (e.g., technologies to develop)?

Panel Presentation: Emerging or Potentially Promising Technologies—How To Develop and/or Optimize Their Use 
(6-Minute Presentations on the Technology, Followed by Discussion)

• Nanotechnology: Erik Rytting (PDF - 1.73 MB)
• Biochemical Techniques: Carolyn Ott (PDF - 864 KB)
   
• High-Throughput –omics: Diana Bianchi (PDF - 580 KB)
• Systems Science, Computational Biology: Brian Cox
   
• Data Management: Peter Basser
   

Breakout Sessions: Emerging or Potentially Promising Technologies—How To Develop and/or Optimize Their Use

• Breakout 1: Nanotechnology (e.g., Nanorobots, Intravascular Sensors): Led by Erik Rytting
• Breakout 2: Biochemical Techniques: Led by Carolyn Ott
   
• Breakout 3: High-Throughput –omics: Led by Diana Bianchi
   
• Breakout 4: Systems Science, Computational Biology: Led by Brian Cox
   
• Breakout 5: Data Management (e.g., Sharing, Manipulation, Reconstruction): Led by Peter Basser
   

Charge to Breakout Groups:

• What are the "adjacent possible" to application in obstetrics for each technology?
• What technologies might be applicable to HPP?
• What technologies need to be developed to address the pathophysiologic process?
• Describe what needs to be done to develop/stimulate/ encourage/facilitate this area to move forward to understand human placental structure and function in real time.
• Are there initial steps that must first occur (e.g., technologies to develop)?